LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Comparison of Aerosol Deposition Between a Cynomolgus Macaque and a 3D Printed Cast Model of the Animal.

    Creppy, Justina / Cabrera, Maria / Kahlaoui, Nidhal / Pardessus, Jeoffrey / Lemaitre, Julien / Naninck, Thibaut / Delache, Benoît / Roseau, Georges / Ducancel, Frédéric / Vecellio, Laurent

    Pharmaceutical research

    2023  Volume 40, Issue 3, Page(s) 765–775

    Abstract: Purpose: Preclinical aerosol studies using animals are essential for evaluating toxic or therapeutic effects on human respiratory tract. Macaques are relevant animal models for respiratory studies, but they are sensitive, expensive and difficult-to- ... ...

    Abstract Purpose: Preclinical aerosol studies using animals are essential for evaluating toxic or therapeutic effects on human respiratory tract. Macaques are relevant animal models for respiratory studies, but they are sensitive, expensive and difficult-to-access.
    Methods: In the context of preliminary studies before animal experiments, we set up an alternative in vitro anatomical model of macaque airways to reduce, refine and replace (3Rs) the animals. We printed an in vitro anatomical cast until the third bronchial division from X-ray computed tomography data of a healthy cynomolgus macaque. This in vitro model was then connected to a respiratory pump to mimic macaque's breathing. We assessed the relevance of this in vitro model, by comparing aerosol deposition patterns obtained with the anatomical model and in three macaques using planar gamma camera imaging. DTPA-
    Results: The data showed no statistical differences between the animal and anatomical in vitro models in terms of total aerosol deposited in the airways. However, the distribution of the deposition in the airways showed a higher deposited fraction in the upper respiratory tract in the animals than the in vitro model for all particle sizes.
    Conclusions: The anatomical printed model appears to be a relevant in vitro tool to predict total aerosol deposition in macaque airways.
    MeSH term(s) Animals ; Humans ; Administration, Inhalation ; Lung ; Aerosols ; Nebulizers and Vaporizers ; Macaca ; Printing, Three-Dimensional ; Particle Size
    Chemical Substances Aerosols
    Language English
    Publishing date 2023-01-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 843063-9
    ISSN 1573-904X ; 0724-8741 ; 0739-0742
    ISSN (online) 1573-904X
    ISSN 0724-8741 ; 0739-0742
    DOI 10.1007/s11095-022-03466-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection.

    Reynard, Olivier / Gonzalez, Claudia / Dumont, Claire / Iampietro, Mathieu / Ferren, Marion / Le Guellec, Sandrine / Laurie, Lajoie / Mathieu, Cyrille / Carpentier, Gabrielle / Roseau, Georges / Bovier, Francesca T / Zhu, Yun / Le Pennec, Deborah / Montharu, Jérome / Addetia, Amin / Greninger, Alexander L / Alabi, Christopher A / Moscona, Anne / Vecellio, Laurent /
    Porotto, Matteo / Horvat, Branka

    Research square

    2022  

    Abstract: Measles is the most contagious airborne viral infection and the leading cause of child death among vaccine-preventable diseases. We show here that aerosolized lipopeptide fusion inhibitors, derived from heptad-repeat regions of the measles virus (MeV) ... ...

    Abstract Measles is the most contagious airborne viral infection and the leading cause of child death among vaccine-preventable diseases. We show here that aerosolized lipopeptide fusion inhibitors, derived from heptad-repeat regions of the measles virus (MeV) fusion protein, block respiratory MeV infection in a non-human primate model, the cynomolgus macaque. We used a custom-designed mesh nebulizer to ensure efficient aerosol delivery of peptides to the respiratory tract and demonstrated the absence of adverse effects and lung pathology in macaques. The nebulized peptide efficiently prevented MeV infection, resulting in the complete absence of MeV RNA, MeV-infected cells, and MeV-specific humoral responses in treated animals. This strategy provides an additional shield which complements vaccination to fight against respiratory infection, presenting a proof-of-concept for the aerosol delivery of fusion inhibitory peptides to protect against measles and other airborne viruses, including SARS-CoV-2, in case of high-risk exposure, that can be readily translated to human trials.
    Language English
    Publishing date 2022-06-01
    Publishing country United States
    Document type Preprint
    DOI 10.21203/rs.3.rs-1700877/v1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection.

    Reynard, Olivier / Gonzalez, Claudia / Dumont, Claire / Iampietro, Mathieu / Ferren, Marion / Le Guellec, Sandrine / Laurie, Lajoie / Mathieu, Cyrille / Carpentier, Gabrielle / Roseau, Georges / Bovier, Francesca T / Zhu, Yun / Le Pennec, Deborah / Montharu, Jérome / Addetia, Amin / Greninger, Alexander L / Alabi, Christopher A / Brisebard, Elise / Moscona, Anne /
    Vecellio, Laurent / Porotto, Matteo / Horvat, Branka

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 6439

    Abstract: Measles is the most contagious airborne viral infection and the leading cause of child death among vaccine-preventable diseases. We show here that aerosolized lipopeptide fusion inhibitor, derived from heptad-repeat regions of the measles virus (MeV) ... ...

    Abstract Measles is the most contagious airborne viral infection and the leading cause of child death among vaccine-preventable diseases. We show here that aerosolized lipopeptide fusion inhibitor, derived from heptad-repeat regions of the measles virus (MeV) fusion protein, blocks respiratory MeV infection in a non-human primate model, the cynomolgus macaque. We use a custom-designed mesh nebulizer to ensure efficient aerosol delivery of peptide to the respiratory tract and demonstrate the absence of adverse effects and lung pathology in macaques. The nebulized peptide efficiently prevents MeV infection, resulting in the complete absence of MeV RNA, MeV-infected cells, and MeV-specific humoral responses in treated animals. This strategy provides an additional means to fight against respiratory infection in non-vaccinated people, that can be readily translated to human trials. It presents a proof-of-concept for the aerosol delivery of fusion inhibitory peptides to protect against measles and other airborne viruses, including SARS-CoV-2, in case of high-risk exposure.
    MeSH term(s) Animals ; Humans ; Measles virus ; SARS-CoV-2 ; COVID-19/prevention & control ; Measles/prevention & control ; Viral Fusion Proteins/metabolism ; Peptides/pharmacology ; Macaca fascicularis/metabolism
    Chemical Substances Viral Fusion Proteins ; Peptides
    Language English
    Publishing date 2022-10-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-33832-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top